조혈모세포이식 후 중환자실 치료를 받은 소아 환자의 예후 예견 인자 분석 = Prediction of Prognosis for Children Cared in Intensive Care Unit (ICU) after Hematopoietic Stem Cell Transplantation (HSCT)

다국어 초록 (Multilingual Abstract)

Background: Pediatric Index of Mortality 2 (PIM2) is a useful scoring system for the prediction of prognosis, and Oncological Pediatric Risk of Mortality (O-PRISM) for ICU support in children with HSCT. We investigated prognostic prediction and risk factors for survival through early detection of admission to ICU after HSCT.
Methods: We reviewed retrospectively medical records of children cared for in ICU after HSCT between 2004 and 2010. Patients who died within 2 hours after admittance to ICU were excluded. We analyzed the worst parameters in ICU by a t-test, Cox-regression, multiple logistic regression and a receiver operating characteristics curve (ROC).
Results: 54 children, with fifty-five disease events, were admitted to ICU after HSCT. Sixteen children were diagnosed with high-risk disease status and 8 with non-malignant diseases. Stem cells were sourced from 14 matched siblings, 22 unrelated donors and 19 cord bloods. The median duration in ICU was 8.5 days (0.5−110). The reasons for admission to ICU were 32 pulmonary, 14 neurologic, and 9 hemodynamic events. Six patients (11.1%) survived after intensive care. The factor indicating discharge with survival was mental status (p = 0.04), although other factors included FiO_2, prothrombin time, potassium, and pupil reflex in univariate analysis. In multiple logistic regression, there were significant factors of PaCO_2 (p = 0.028), O-PRISM (p = 0.039), and PIM2 (p = 0.004) for prognosis. For prediction of prognosis, O-PRISM (p = 0.019) was superior to PIM2 (p = 0.435) in intensive care children after HSCT.
Conclusions: O-PRISM might be a predictable scoring system for children with ICU support, and the Glasgow coma scale and PaCO_2 were more reliable prognostic factors in the post-HSCT period.

참고문헌 (Reference)

• 1 황희승, "단일 병원에서 소아 중환자의 예후인자 예측을 위한 PIM2 (pediatric index of mortality 2)와 PRIMS III (pediatric risk of mortality)의 유효성 평가 - 후향적 조사" 대한소아과학회 51 (51): 1158-1164, 2008
• 2 Slater A, "The suitability of the Pediatric Index of Mortality (PIM), PIM2, the Pediatric Risk of Mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand" 5 : 447-454, 2004
• 3 Hayes C, "The outcome of children requiring admission to an intensive care unit following bone marrow transplantation" 102 : 666-670, 1998
• 4 Hayes C, "The outcome of children requiring admission to an intensive care unit following bone marrow transplantation" 102 : 666-670, 1998
• 5 Schneider DT, "Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children" 29 : 383-389, 2002
• 6 Cheuk DK, "Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant" 22 : 1-9, 2004
• 7 Pollack MM, "Pediatric risk of mortality (PRISM) score" 16 : 1110-1116, 1988
• 8 Slater A, "Paediatric Index of Mortality (PIM) Study Group: PIM2: a revised version of the Paediatric Index of Mortality" 29 : 278-285, 2003
• 9 Pollack MM, "PRISM III: an updated Pediatric Risk of Mortality score" 24 : 743-752, 1996
• 10 Warwick AB, "Outcomes following mechanical ventilation in children undergoing bone marrow transplantation" 22 : 87-94, 1998
• 11 Paz HL, "Outcome of patients requiring medical ICU admission following bone marrow transplantation" 104 : 527-531, 1993
• 12 Pène F, "Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports" 24 : 643-649, 2006
• 13 Huaringa AJ, "Outcome of bone marrow transplantation patients requiring mechanical ventilation" 28 : 1014-1017, 2000
• 14 Haire WD, "Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation" 30 (30): S257-262, 2002
• 15 Bratton SL, "Lower hospital mortality and complications after pediatric hematopoietic stem cell transplantation" 36 : 923-927, 2008
• 16 Schneider DT, "Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children" 25 : 1079-1086, 2000
• 17 Afessa B, "Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients" 31 : 1715-1721, 2003
• 18 van Gestel JP, "Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis" 36 : 2898-2904, 2008
• 19 Matulis M, "Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections" 17 : 130-139, 2002
• 20 Savaşan S, "Current issues in pediatric stem cell transplantation" 25 : 519-540, 2005
• 21 Afessa B, "Critical care of the hematopoietic stem cell transplant recipient" 26 : 133-150, 2010
• 22 Fagon JY, "Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model" 19 : 137-144, 1993
• 23 Kache S, "Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation" 10 : 299-303, 2006
• 24 Lamia B, "Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU" 32 : 1560-1568, 2006
• 25 Jackson SR, "Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors" 21 : 697-704, 1998